Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-09
2011-08-09
Anderson, James (Department: 1629)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07994216
ABSTRACT:
Methods and compositions are presented in which catechin-containing compositions have statistically significant and strong therapeutic effect in the treatment of LUTS wherein such compositions are stage-specifically administered to a patient diagnosed with HG-PIN and optional coexistent BPH.
REFERENCES:
patent: 5605929 (1997-02-01), Liao et al.
patent: 7070816 (2006-07-01), Newmark et al.
Bettuzzi et al. Cancer Res., vol. 66, No. 2, Jan. 15, 2006, pp. 1234-1240.
Roehrborn, C.G. Rev. Urol., 2004, vol. 6, No. 3, pp. 121-127.
Gupta et al. PNAS, 2001, vol. 98, pp. 10350-10355.
Chow et al. Clinical Cancer Research, 2005, vol. 11, No. 12, pp. 4627-4633.
Pytel et al. Urologiia, 2004, vol. 2, pp. 3-7 (Abstract attached).
Lowe et al. Current Prostate Reports, 2004, vol. 2, pp. 133-136.
Chow, H-H. Sherry, Pharmacokinetics and Safety of Green Tea Polyphenols after Multiple-Done Administration of Epigallacatechin Gallate and Polyphenon E in Healthy Individuals, Clinical Cancer Research, Aug. 15, 2003, vol. 9, pp. 3312-3319, National Cancer Institute, Bethesda, Maryland.
Khan M.D., Masood A., Chemoprevention and Prostate Cancer, Reviews in Urology, 2003; 5(1): 61-63, Med Reviews, LLC.
Steiner, Mitchell S., Phase IIA Clinical Trial to Test the Efficacy and Safety of Toremifene in Men with High-Grade Prostatic Intraepithelial Neoplasia, , Clinical Prostate Cancer, vol. 2, No. 1, 24-31, 2003.
Price, David, Toremifene for the Prevention of Prostate Cancer in Men With High Grade Prostatic Intraepithelial Neoplasia: Results of a Double-Blind, Placebo Controlled, Phase IIB Clinical Trial, The Journal of Urology, vol. 176, pp. 965-971, Sep. 2006, The American Urological Association.
Bettuzzi Saverio
Corti Arnaldo
Anderson James
Fish & Associates PC
Genprofiler, S.R.L.
LandOfFree
Stage-specific reduction of LUTS in prostate disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stage-specific reduction of LUTS in prostate disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stage-specific reduction of LUTS in prostate disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2707969